Your Navigator Learning Hub: Guiding Personalized Patient Journeys

Welcome, Navigator!

Your “Clinical Reflections” quiz results highlight your dedication to patient-centered care. The ADVENT program brings together emerging data and perspectives to support informed clinical decision-making. Explore curated resources to help translate the latest insights into practice.

What You'll Discover in Your Navigator Learning Hub

Dive into curated resources to help tailor the treatment journey and continue to translate data-driven results into personalized care.

Ready to push boundaries? Explore your personalized resources and lead the way toward better health outcomes

Role of Type 2 Cytokines in Asthma and COPD

Type 2 Inflammation

2 min

expert video

Role of Type 2 Cytokines in Asthma and COPD

Uncovering the Impact of Moderate COPD Exacerbations

Pulmonology

5 min

interactivity

Uncovering the Impact of Moderate COPD Exacerbations

MAT-GLB-2602169 - 1.0 - 05/2026

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: EcuadorChange country/region